Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone.
Hug
V
V
Department of Medical Oncology (Breast Medical Oncology), and Gynecology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Kau
S
S
Hortobagyi
G N
GN
Jones
L
L
D000311:Adrenal Glands / Q000187:drug effects / Q000503:physiopathology; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D002277:Carcinoma / Q000188:drug therapy* / Q000503:physiopathology; D004334:Drug Administration Schedule; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged
D004958:Estradiol; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone